- 全部删除
- 您的购物车当前为空
RF9 is an effective and selective antagonist of the Neuropeptide FF receptor (Kis: 58±5 and 75±9 nM for hNPFF1R and hNPFF2R, respectively).
RF9 is an effective and selective antagonist of the Neuropeptide FF receptor (Kis: 58±5 and 75±9 nM for hNPFF1R and hNPFF2R, respectively).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | 待估 | 35日内发货 | |
5 mg | 待估 | 35日内发货 | |
10 mg | 待估 | 35日内发货 |
RF9 相关产品
产品描述 | RF9 is an effective and selective antagonist of the Neuropeptide FF receptor (Kis: 58±5 and 75±9 nM for hNPFF1R and hNPFF2R, respectively). |
靶点活性 | NPFF1R (human):58±5 nM (Ki), NPFF2R (human):75±9 nM(Ki) |
体内活性 | RF9 (10 μg) infused alone does not result in a significant alteration of MAP or heart rate. When NPFF is applied in conjunction with RF9, MAP, and heart rate increases evoked by NPFF are significantly blocked. It is worthy to note that RF9 (30 nmol) significantly reduces the hypothermia induced by morphine (5 nmol) [1][2]. |
分子量 | 482.62 |
分子式 | C26H38N6O3 |
CAS No. | 876310-60-0 |
密度 | 1.42 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 150 mg/mL (310.80 mM), Sonication and heating are recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容